Reference
Luhnen M, et al. Health Economic Evaluations of Sofosbuvir for Treatment of Chronic Hepatitis C: a Systematic Review. Applied Health Economics and Health Policy : 21 Jun 2016. Available from: URL: http://dx.doi.org/10.1007/s40258-016-0253-2
Rights and permissions
About this article
Cite this article
Sofosbuvir triple regimens cost effective for chronic HCV. PharmacoEcon Outcomes News 756, 31 (2016). https://doi.org/10.1007/s40274-016-3180-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3180-4